Christopher De La Paz, APRN

Christopher De La Paz practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Christopher De La Paz's NPI, 1669026738, was assigned on July 28, 2019. Christopher De La Paz holds Florida license APRN11003495.

Christopher De La Paz's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Christopher De La Paz's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher De La Paz practices. Vendor and product names are available with a free account.

Primary care is Christopher De La Paz's primary specialty in the NPI Registry, under taxonomy code 363LP2300X. Christopher De La Paz is board certified in adult-gerontology primary care nurse practitioner by the American Academy of Nurse Practitioners Certification Program (AANPCP). Christopher De La Paz is licensed in Florida.

CMS data shows 50 Medicare services from Christopher De La Paz across 2 procedure codes in 2024, all of them office visits, for 34 Medicare patients. Medicare paid $4,507 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 34 Medicare patients who saw Christopher De La Paz in 2024. The largest group is 65 to 74, with 19 patients. 68% of them have high blood pressure, and 53% have high cholesterol. 38% are also on Medicaid. Their average risk score is 3.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Christopher De La Paz's median patient age at 66, with 36% women.

In 2024, Christopher De La Paz wrote 455 Medicare Part D claims for 65 patients. 81% of them were for generic drugs. CMS names the drug for 226 of them, across 10 drugs with 11 or more claims each, at $224,186 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Christopher De La Paz for performance year 2024, reported as part of a group. Christopher De La Paz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Christopher De La Paz as offering telehealth.

CMS Open Payments shows 40 general payments to Christopher De La Paz from 13 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 89% of the total. Sanofi and Genzyme US Companies paid the most, $420.